STEMIN and YAP5SA synthetic modified mRNAs regenerate and repair infarcted mouse hearts

Abstract

Introduction: The adult heart lacks the regenerative capacity to self-repair. Serum response factor (SRF) is essential for heart organogenesis, sarcomerogenesis, and contractility. SRF interacts with co-factors, such as NKX2.5 and GATA4, required for cardiac specified gene activity. ETS factors such as ELK1 interact with SRF and drive cell replication. To weaken SRF interactions with NKX2.5 and GATA4, one mutant, SRF153(A3) named STEMIN, did not bind CArG boxes, yet induced stem cell factors such as NANOG and OCT4, cardiomyocyte dedifferentiation, and cell cycle reentry. The mutant YAP5SA of the Hippo pathway also promotes cardiomyocyte proliferation and growth.

Aim: Infarcted adult mouse hearts were injected with translatable STEMIN and YAP5SA mmRNA to evaluate their clinical potential,

Methods and Results: Mice were pulsed one day later with alpha-EDU and then heart sections were DAPI stained. Replicating cells were identified by immuno-staining against members of the DNA replisome pathway that mark entry to S phase of the cell cycle. Echocardiography was used to determine cardiac function following infarcts and mRNA treatment. To monitor cardiac wall repair, microscopic analysis was performed, and the extent of myocardial fibrosis was analyzed for immune cell infiltration. Injections of STEMIN and YAP5SA mmRNA into the left ventricles of infarcted adult mice promoted a greater than 17-fold increase in the DAPI stained and alpha-EDU marked cardiomyocyte nuclei, within a day. We observed de novo expression of phospho-histone H3, ORC2, MCM2, and CLASPIN. Cardiac function was significantly improved by four weeks post-infarct, and fibrosis and immune cell infiltration were diminished in hearts treated with STEMIN and YAP5SA mmRNA than each alone.

Conclusion: STEMIN and YAP5SA mmRNA improved cardiac function and myocardial fibrosis in left ventricles of infarcted adult mice. The combinatorial use of mmRNA encoding STEMIN and YAP5SA has the potential to become a powerful clinical strategy to treat human heart disease.

Keywords

Cardiac regeneration / synthetic mRNA / heart delivery / serum response factor / STEMIN / hippo pathway / YAP5SA

References

[1] den Berg C, Elliott DA, Braam SR, Mummery CL, Davis R. Differentiation of human pluripotent stem cells to cardiomyocytes under defined conditions.Methods Mol Biol2016;1353:163-80.

[2] Zhang J,Soerens AG.Functional cardiomyocytes derived from human induced pluripotent stem cells.Circ Res2009;104:e30-e41. PMCID:PMC2741334

[3] Narita T.Bone Marrow-derived mesenchymal stem cells for the treatment of heart failure.Heart Fail Rev2015;20:53-68

[4] Romagnuolo R.Programming cells for cardiac repair.Curr Opin Biotechnol2017;47:43-50.

[5] futile cycle in cell therapy.Nat Biotech2017;35:291

[6] Niu Z,Conway SJ.Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart.Proc Natl Acad Sci USA2008;105:17824-829. PMCID:PMC2584699

[7] Mercola M,P ,MD .Cardiac muscle regeneration: lessons from development.Genes Dev2011;25:299-309. PMCID:PMC3042154

[8] Srivastava D.Knowing in your heart what’s right.Trends Cell Biol1997;7:447-53.

[9] Sanger JW,Fan Y,Sanger JM.Assembly and dynamics of myofibrils.J Biomed Biotechnol2010;858606 PMCID:PMC2896905

[10] Ahuja P,Perriard JC.Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes.J Cell Sci2004;117:3295-306.

[11] Porrello ER,Simpson E.Transient Regenerative Potential of the Neonatal Mouse Heart.Science2011;331:1078-80. PMCID:PMC3099478

[12] Foglia MJ.Building and re-building the heart by cardiomyocyte proliferation.Development2016;143:729-40. PMCID:PMC4813344

[13] Ocampo A.In vivo amelioration of age-associated hallmarks by partial reprogramming.Cell2016;167:719-1733. PMCID:PMC5679279

[14] Chen Y.Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.Science2021;373:1537-40.

[15] Xiao S,Muili AB.Mutant Serum Response factor, SRF153(A3), in combination with mutant YAP5SA drive cardiomyocytes to a replicative state.J Cardiovasc Aging2022;6:17

[16] Xiao Y,Wang J.Hippo/Yap Signaling in cardiac development and regeneration.Curr Treat Options Cardiovasc Med2016;18:1-9.

[17] National Research Council .Guide for the care and use of laboratory animals, 8th ed. Washington, DC: The National Academies Press, 2011.

[18] Ahn D,Moon C,Lakatta EG.Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice.Am J Physiol Heart Circ Physiol2004;286:H1201-H1207.

[19] Gao S.Echocardiography in mice.Curr Protoc Mouse Biol2011;1:71-83. PMCID:PMC3130310

[20] Leman AR.The Replication Fork: Understanding the Eukaryotic Replication Machinery and the Challenges to Genome Duplication.Genes2013;4:1-32. PMCID:PMC3627427

[21] Li J,Peng X.Indirect immunostaining on mouse embryonic heart for the detection of proliferated cardiomyocyte. In: Peng X, Antonyak M. editors. Cardiovascular development. Methods in molecular biology (methods and protocols). Totowa, NJ: Humana Press, 2012, p. 843.

[22] Hasegawa S,Nagano H,Mitchell RN.Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and Am J Pathol 1998;153:69-79. PMCID:PMC1852929

[23] Vafadarnejad E,Krampert L.Dynamics of cardiac neutrophil diversity in murine myocardial infarction.Circ Res2020;127:e232-e49.

[24] Dong IC.Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair.JCI Insight2019;4:e125437. PMCID:PMC6777833

[25] Senís E,Wilkening S.AAV vector-mediated in vivo reprogramming into pluripotency.Nat Commun2018;9:2651

[26] Liu S.Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction.Sci Transl Med2021;13:eabd6892.